Li Da-Qiang, Wang Lei, Fei Fei, Hou Yi-Feng, Luo Jian-Min, Zeng Rong, Wu Jiong, Lu Jin-Song, Di Gen-Hong, Ou Zhou-Luo, Xia Qi-Chang, Shen Zhen-Zhou, Shao Zhi-Min
Department of Breast Surgery, Breast Cancer Institute, Cancer Hospital/Cancer Institute, Fudan University, Shanghai, P. R. China.
Proteomics. 2006 Jun;6(11):3352-68. doi: 10.1002/pmic.200500617.
To better understand the molecular mechanisms underlying breast cancer metastasis and search for potential markers for metastatic progression, we have developed a highly metastatic variant of human MDA-MB-435 breast cancer cell line through in vivo stepwise selection of pulmonary metastatic cells caused by parental MDA-MB-435 cells in the athymic mice. Comparative proteomic analysis using 2-DE and LC-IT-MS revealed that 102 protein spots were reproducibly altered more than three-fold between the selected variant and its parental counterpart. Eleven differentially expressed protein spots were identified with high confidence using SEQUEST with uninterpreted tandem mass raw data. Cathepsin D precursor, peroxiredoxin 6 (PDX6), heat shock protein 27 (HSP27), HSP60, tropomyosin 1 (TPM1), TPM2, TPM3, TPM4, 14-3-3 protein epsilon, and tumor protein D54 were up-regulated in the highly metastatic variant, whereas alpha B-crystalline (CRAB) was only detected in its parental counterpart. Differential expression was confirmed for four proteins including PDX6, CRAB, TPM4, and HSP60 by real-time quantitative PCR and Western blotting analysis in our model. Immunohistochemical analysis in 80 breast cancer donors demonstrated a significant association of TPM4 (p = 0.002), HSP60 (p = 0.001), PDX6 (p = 0.002) but not CRAB (p = 0.113) staining with the presence of lymph node metastasis. In addition, TPM4 staining was also associated with clinical stage (p = 0.000), but no significant association was found between TPM4, PDX6, CRAB, and HSP60 expression and tumor size, hormone receptor, and HER-2 status (p > 0.05). The functional implication of these identified proteins was also discussed. These proteomic data are valuable and informative for understanding breast cancer metastasis and searching for potential markers for metastatic progression.
为了更好地理解乳腺癌转移的分子机制并寻找转移进展的潜在标志物,我们通过在无胸腺小鼠体内对亲本MDA-MB-435细胞引起的肺转移细胞进行逐步选择,建立了人MDA-MB-435乳腺癌细胞系的高转移变体。使用二维电泳(2-DE)和液相色谱-离子阱-质谱(LC-IT-MS)进行的比较蛋白质组学分析显示,在所选变体与其亲本对应物之间,有102个蛋白点的变化具有可重复性且变化倍数超过三倍。使用SEQUEST对未解释的串联质谱原始数据进行高可信度鉴定,确定了11个差异表达的蛋白点。组织蛋白酶D前体、过氧化物酶体增殖物激活受体6(PDX6)、热休克蛋白27(HSP27)、HSP60、原肌球蛋白1(TPM1)、TPM2、TPM3、TPM4、14-3-3蛋白ε和肿瘤蛋白D54在高转移变体中上调,而αB-晶状体蛋白(CRAB)仅在其亲本对应物中检测到。在我们的模型中,通过实时定量PCR和蛋白质印迹分析证实了包括PDX6、CRAB、TPM4和HSP60在内的四种蛋白质的差异表达。对80例乳腺癌供体的免疫组织化学分析表明,TPM4(p = 0.002)、HSP60(p = 0.001)、PDX6(p = 0.002)染色与淋巴结转移的存在显著相关,但CRAB(p = 0.113)染色与淋巴结转移无显著相关性。此外,TPM4染色也与临床分期相关(p = 0.000),但未发现TPM4、PDX6、CRAB和HSP60表达与肿瘤大小、激素受体和HER-2状态之间存在显著相关性(p > 0.05)。还讨论了这些鉴定出的蛋白质的功能意义。这些蛋白质组学数据对于理解乳腺癌转移和寻找转移进展的潜在标志物具有重要价值和信息意义。